ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2026
Helical intensity-modulated radiation therapy vs. C-arm-based volumetric modulated arc therapy for sinonasal tumours: organ at risk sparing and treatment efficiency.
Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeSinonasal tumours present major radiotherapy challenges because of their proximity to the optic nerves, chiasm, and brainstem. This study aimed to evaluate helical intensity-modulated radiation therapy (HIMRT) and volumetric modulated arc therapy (VMAT), including coplanar and noncoplanar approaches, by integrating plan quality and treatment efficiency. MATERIALS AND
methodsA retrospective planning analysis of 467 patients with sinonasal tumours was conducted using HIMRT and VMAT planning techniques, whereby HIMRT with jaw widths of 1.0, 2.5, and 5.0 cm were compared with coplanar and noncoplanar VMAT plans. The planning evaluation included dose coverage (D95, D98, D2, D50%), homogeneity index, and dose spillage metrics (V10-V90%). Organ-at-risk doses were assessed for the optic apparatus, brainstem, and parotids. Efficiency was evaluated via monitor units and beam-on time, whereas delivery accuracy was validated via OSL dosimetry and gamma analysis.
resultsBoth techniques achieved conformal dose coverage and OAR sparing. While HIMRT with narrow jaws improved conformity, it required substantially longer beam-on times. The VMAT plans provided comparable coverage and OAR protection with fewer hotspots, and they delivered treatment in less time. Noncoplanar VMAT offered only minor gains. Phantom validation confirmed the dose delivery accuracy, with OSLD deviations < 5% and gamma passes rates > 97%.
conclusionWhile HIMRT and VMAT are both effective for sinonasal radiotherapy, VMAT offers superior efficiency with comparable plan quality. Therefore, HIMRT may be reserved for anatomically complex cases where marginal conformity benefits justify longer treatment times.
Indexed as
Identifiers
42347872What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.